Alvotech Humira Settlement Sets Up Interchangeable Adalimumab Showdown
US Launch Date Matches That Of BI’s Cyltezo Interchangeable Humira Biosimilar
Alvotech and Boehringer Ingelheim could launch rival interchangeable Humira biosimilars on the same date • Source: Thomas LENNE / Alamy Stock Photo 
